protoscript mlv reverse transcriptase Search Results


98
New England Biolabs protoscript m mulv reverse transcriptase
Protoscript M Mulv Reverse Transcriptase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript m mulv reverse transcriptase/product/New England Biolabs
Average 98 stars, based on 1 article reviews
protoscript m mulv reverse transcriptase - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

98
New England Biolabs protoscript moloney murine leukemia virus m mulv taq rt pcr kit
Protoscript Moloney Murine Leukemia Virus M Mulv Taq Rt Pcr Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript moloney murine leukemia virus m mulv taq rt pcr kit/product/New England Biolabs
Average 98 stars, based on 1 article reviews
protoscript moloney murine leukemia virus m mulv taq rt pcr kit - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

96
New England Biolabs protoscript m mulv first strand cdna synthesis kit
Protoscript M Mulv First Strand Cdna Synthesis Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript m mulv first strand cdna synthesis kit/product/New England Biolabs
Average 96 stars, based on 1 article reviews
protoscript m mulv first strand cdna synthesis kit - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

97
New England Biolabs protoscript mlv reverse transcriptase
Protoscript Mlv Reverse Transcriptase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript mlv reverse transcriptase/product/New England Biolabs
Average 97 stars, based on 1 article reviews
protoscript mlv reverse transcriptase - by Bioz Stars, 2026-06
97/100 stars
  Buy from Supplier

98
New England Biolabs protoscript m mulv taq reverse transcriptase polymerase chain reaction rt pcr kit
Protoscript M Mulv Taq Reverse Transcriptase Polymerase Chain Reaction Rt Pcr Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript m mulv taq reverse transcriptase polymerase chain reaction rt pcr kit/product/New England Biolabs
Average 98 stars, based on 1 article reviews
protoscript m mulv taq reverse transcriptase polymerase chain reaction rt pcr kit - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

97
New England Biolabs mmlv reverse transcriptase
Mmlv Reverse Transcriptase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mmlv reverse transcriptase/product/New England Biolabs
Average 97 stars, based on 1 article reviews
mmlv reverse transcriptase - by Bioz Stars, 2026-06
97/100 stars
  Buy from Supplier

98
New England Biolabs rt pcr kit
Myosin VI SI potentiates evoked exocytosis. (A) <t>RT-PCR</t> analysis of myosin VI isoform expression. β-Actin primers were used as a control. (B) Cartoons of GFP-tagged myosin VI constructs. The motor domain (purple) contains the actin- and ATP-binding sites, the reverse gear (761–814 aa, yellow) determines the unique directionality of myosin VI movement along actin, and the tail domain (orange) in the myosin VI SI (1,262 aa), but not the myosin VI NI (1,253 aa), contains a 9-aa insert. GFP-MyoVI-tail constructs lack the motor domain and are unable to interact with F-actin. (C) GFP-MyoVI protein expression in PC12 cells was evaluated by Western blotting using an anti–myosin VI antibody. Arrows indicate GFP-MyoVI-full proteins (175 kD) and GFP-MyoVI-tail proteins (85 kD). (D) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-NIfull. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP ( n = 3). (E) NPY-hPLAP release was measured in wild-type (wt) and myosin VI stable knockdown (KD) PC12 cells overexpressing GFP (control), GFP-MyoVI-SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull (+GFP-MyoVI-NIfull). Released NPY-hPLAP is expressed as a percentage of wild-type PC12 cells ( n = 3). Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Rt Pcr Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rt pcr kit/product/New England Biolabs
Average 98 stars, based on 1 article reviews
rt pcr kit - by Bioz Stars, 2026-06
98/100 stars
  Buy from Supplier

99
New England Biolabs protoscript ii first strand cdna synthesis kit
Myosin VI SI potentiates evoked exocytosis. (A) <t>RT-PCR</t> analysis of myosin VI isoform expression. β-Actin primers were used as a control. (B) Cartoons of GFP-tagged myosin VI constructs. The motor domain (purple) contains the actin- and ATP-binding sites, the reverse gear (761–814 aa, yellow) determines the unique directionality of myosin VI movement along actin, and the tail domain (orange) in the myosin VI SI (1,262 aa), but not the myosin VI NI (1,253 aa), contains a 9-aa insert. GFP-MyoVI-tail constructs lack the motor domain and are unable to interact with F-actin. (C) GFP-MyoVI protein expression in PC12 cells was evaluated by Western blotting using an anti–myosin VI antibody. Arrows indicate GFP-MyoVI-full proteins (175 kD) and GFP-MyoVI-tail proteins (85 kD). (D) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-NIfull. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP ( n = 3). (E) NPY-hPLAP release was measured in wild-type (wt) and myosin VI stable knockdown (KD) PC12 cells overexpressing GFP (control), GFP-MyoVI-SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull (+GFP-MyoVI-NIfull). Released NPY-hPLAP is expressed as a percentage of wild-type PC12 cells ( n = 3). Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Protoscript Ii First Strand Cdna Synthesis Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript ii first strand cdna synthesis kit/product/New England Biolabs
Average 99 stars, based on 1 article reviews
protoscript ii first strand cdna synthesis kit - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

96
New England Biolabs protoscript m mulv taq rt pcr kit
Myosin VI SI potentiates evoked exocytosis. (A) <t>RT-PCR</t> analysis of myosin VI isoform expression. β-Actin primers were used as a control. (B) Cartoons of GFP-tagged myosin VI constructs. The motor domain (purple) contains the actin- and ATP-binding sites, the reverse gear (761–814 aa, yellow) determines the unique directionality of myosin VI movement along actin, and the tail domain (orange) in the myosin VI SI (1,262 aa), but not the myosin VI NI (1,253 aa), contains a 9-aa insert. GFP-MyoVI-tail constructs lack the motor domain and are unable to interact with F-actin. (C) GFP-MyoVI protein expression in PC12 cells was evaluated by Western blotting using an anti–myosin VI antibody. Arrows indicate GFP-MyoVI-full proteins (175 kD) and GFP-MyoVI-tail proteins (85 kD). (D) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-NIfull. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP ( n = 3). (E) NPY-hPLAP release was measured in wild-type (wt) and myosin VI stable knockdown (KD) PC12 cells overexpressing GFP (control), GFP-MyoVI-SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull (+GFP-MyoVI-NIfull). Released NPY-hPLAP is expressed as a percentage of wild-type PC12 cells ( n = 3). Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Protoscript M Mulv Taq Rt Pcr Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript m mulv taq rt pcr kit/product/New England Biolabs
Average 96 stars, based on 1 article reviews
protoscript m mulv taq rt pcr kit - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

96
New England Biolabs m mulv reverse transcription system
Myosin VI SI potentiates evoked exocytosis. (A) <t>RT-PCR</t> analysis of myosin VI isoform expression. β-Actin primers were used as a control. (B) Cartoons of GFP-tagged myosin VI constructs. The motor domain (purple) contains the actin- and ATP-binding sites, the reverse gear (761–814 aa, yellow) determines the unique directionality of myosin VI movement along actin, and the tail domain (orange) in the myosin VI SI (1,262 aa), but not the myosin VI NI (1,253 aa), contains a 9-aa insert. GFP-MyoVI-tail constructs lack the motor domain and are unable to interact with F-actin. (C) GFP-MyoVI protein expression in PC12 cells was evaluated by Western blotting using an anti–myosin VI antibody. Arrows indicate GFP-MyoVI-full proteins (175 kD) and GFP-MyoVI-tail proteins (85 kD). (D) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-NIfull. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP ( n = 3). (E) NPY-hPLAP release was measured in wild-type (wt) and myosin VI stable knockdown (KD) PC12 cells overexpressing GFP (control), GFP-MyoVI-SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull (+GFP-MyoVI-NIfull). Released NPY-hPLAP is expressed as a percentage of wild-type PC12 cells ( n = 3). Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
M Mulv Reverse Transcription System, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/m mulv reverse transcription system/product/New England Biolabs
Average 96 stars, based on 1 article reviews
m mulv reverse transcription system - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

99
New England Biolabs protoscript m mulv reverse transcription kit
Myosin VI SI potentiates evoked exocytosis. (A) <t>RT-PCR</t> analysis of myosin VI isoform expression. β-Actin primers were used as a control. (B) Cartoons of GFP-tagged myosin VI constructs. The motor domain (purple) contains the actin- and ATP-binding sites, the reverse gear (761–814 aa, yellow) determines the unique directionality of myosin VI movement along actin, and the tail domain (orange) in the myosin VI SI (1,262 aa), but not the myosin VI NI (1,253 aa), contains a 9-aa insert. GFP-MyoVI-tail constructs lack the motor domain and are unable to interact with F-actin. (C) GFP-MyoVI protein expression in PC12 cells was evaluated by Western blotting using an anti–myosin VI antibody. Arrows indicate GFP-MyoVI-full proteins (175 kD) and GFP-MyoVI-tail proteins (85 kD). (D) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-NIfull. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP ( n = 3). (E) NPY-hPLAP release was measured in wild-type (wt) and myosin VI stable knockdown (KD) PC12 cells overexpressing GFP (control), GFP-MyoVI-SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull (+GFP-MyoVI-NIfull). Released NPY-hPLAP is expressed as a percentage of wild-type PC12 cells ( n = 3). Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Protoscript M Mulv Reverse Transcription Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/protoscript m mulv reverse transcription kit/product/New England Biolabs
Average 99 stars, based on 1 article reviews
protoscript m mulv reverse transcription kit - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

Image Search Results


Myosin VI SI potentiates evoked exocytosis. (A) RT-PCR analysis of myosin VI isoform expression. β-Actin primers were used as a control. (B) Cartoons of GFP-tagged myosin VI constructs. The motor domain (purple) contains the actin- and ATP-binding sites, the reverse gear (761–814 aa, yellow) determines the unique directionality of myosin VI movement along actin, and the tail domain (orange) in the myosin VI SI (1,262 aa), but not the myosin VI NI (1,253 aa), contains a 9-aa insert. GFP-MyoVI-tail constructs lack the motor domain and are unable to interact with F-actin. (C) GFP-MyoVI protein expression in PC12 cells was evaluated by Western blotting using an anti–myosin VI antibody. Arrows indicate GFP-MyoVI-full proteins (175 kD) and GFP-MyoVI-tail proteins (85 kD). (D) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-NIfull. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP ( n = 3). (E) NPY-hPLAP release was measured in wild-type (wt) and myosin VI stable knockdown (KD) PC12 cells overexpressing GFP (control), GFP-MyoVI-SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull (+GFP-MyoVI-NIfull). Released NPY-hPLAP is expressed as a percentage of wild-type PC12 cells ( n = 3). Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Journal: The Journal of Cell Biology

Article Title: Myosin VI small insert isoform maintains exocytosis by tethering secretory granules to the cortical actin

doi: 10.1083/jcb.201204092

Figure Lengend Snippet: Myosin VI SI potentiates evoked exocytosis. (A) RT-PCR analysis of myosin VI isoform expression. β-Actin primers were used as a control. (B) Cartoons of GFP-tagged myosin VI constructs. The motor domain (purple) contains the actin- and ATP-binding sites, the reverse gear (761–814 aa, yellow) determines the unique directionality of myosin VI movement along actin, and the tail domain (orange) in the myosin VI SI (1,262 aa), but not the myosin VI NI (1,253 aa), contains a 9-aa insert. GFP-MyoVI-tail constructs lack the motor domain and are unable to interact with F-actin. (C) GFP-MyoVI protein expression in PC12 cells was evaluated by Western blotting using an anti–myosin VI antibody. Arrows indicate GFP-MyoVI-full proteins (175 kD) and GFP-MyoVI-tail proteins (85 kD). (D) NPY-hPLAP release was evaluated using a double-stimulation protocol in PC12 cells expressing GFP (control), GFP-MyoVI-SIfull, or GFP-MyoVI-NIfull. Released NPY-hPLAP is expressed as a percentage of total NPY-hPLAP ( n = 3). (E) NPY-hPLAP release was measured in wild-type (wt) and myosin VI stable knockdown (KD) PC12 cells overexpressing GFP (control), GFP-MyoVI-SIfull (+GFP-MyoVI-SIfull), or GFP-MyoVI-NIfull (+GFP-MyoVI-NIfull). Released NPY-hPLAP is expressed as a percentage of wild-type PC12 cells ( n = 3). Error bars are means ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Article Snippet: Poly(A) + RNA was reverse transcribed, and PCR products were produced using the RT-PCR kit (ProtoScript M-MuLV Taq; New England Biolabs, Inc.).

Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Construct, Binding Assay, Western Blot